|
US4407957A
(en)
|
1981-03-13 |
1983-10-04 |
Damon Corporation |
Reversible microencapsulation of a core material
|
|
US4522811A
(en)
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
|
US4946929A
(en)
|
1983-03-22 |
1990-08-07 |
Massachusetts Institute Of Technology |
Bioerodible articles useful as implants and prostheses having predictable degradation rates
|
|
US4879231A
(en)
|
1984-10-30 |
1989-11-07 |
Phillips Petroleum Company |
Transformation of yeasts of the genus pichia
|
|
US4638045A
(en)
|
1985-02-19 |
1987-01-20 |
Massachusetts Institute Of Technology |
Non-peptide polyamino acid bioerodible polymers
|
|
US4806621A
(en)
|
1986-01-21 |
1989-02-21 |
Massachusetts Institute Of Technology |
Biocompatible, bioerodible, hydrophobic, implantable polyimino carbonate article
|
|
CA1340581C
(en)
|
1986-11-20 |
1999-06-08 |
Joseph P. Vacanti |
Chimeric neomorphogenesis of organs by controlled cellular implantation using artificial matrices
|
|
US5759830A
(en)
|
1986-11-20 |
1998-06-02 |
Massachusetts Institute Of Technology |
Three-dimensional fibrous scaffold containing attached cells for producing vascularized tissue in vivo
|
|
US5736372A
(en)
|
1986-11-20 |
1998-04-07 |
Massachusetts Institute Of Technology |
Biodegradable synthetic polymeric fibrous matrix containing chondrocyte for in vivo production of a cartilaginous structure
|
|
US5019379A
(en)
|
1987-07-31 |
1991-05-28 |
Massachusetts Institute Of Technology |
Unsaturated polyanhydrides
|
|
US4929555A
(en)
|
1987-10-19 |
1990-05-29 |
Phillips Petroleum Company |
Pichia transformation
|
|
US5010167A
(en)
|
1989-03-31 |
1991-04-23 |
Massachusetts Institute Of Technology |
Poly(amide-and imide-co-anhydride) for biological application
|
|
US5328470A
(en)
|
1989-03-31 |
1994-07-12 |
The Regents Of The University Of Michigan |
Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
|
|
CA2109085C
(en)
|
1991-04-25 |
2003-03-11 |
Keith E. Dionne |
Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products
|
|
DE69332485T2
(de)
|
1992-08-11 |
2003-11-13 |
The President And Fellows Of Harvard College, Cambridge |
Immunmodulierende peptide
|
|
US5399665A
(en)
|
1992-11-05 |
1995-03-21 |
Massachusetts Institute Of Technology |
Biodegradable polymers for cell transplantation
|
|
US5512600A
(en)
|
1993-01-15 |
1996-04-30 |
Massachusetts Institute Of Technology |
Preparation of bonded fiber structures for cell implantation
|
|
US5514378A
(en)
|
1993-02-01 |
1996-05-07 |
Massachusetts Institute Of Technology |
Biocompatible polymer membranes and methods of preparation of three dimensional membrane structures
|
|
US5543158A
(en)
|
1993-07-23 |
1996-08-06 |
Massachusetts Institute Of Technology |
Biodegradable injectable nanoparticles
|
|
US5716404A
(en)
|
1994-12-16 |
1998-02-10 |
Massachusetts Institute Of Technology |
Breast tissue engineering
|
|
US5643786A
(en)
|
1995-01-27 |
1997-07-01 |
The United States Of America As Represented By The Department Of Health And Human Services |
Method for isolating dendritic cells
|
|
US6123727A
(en)
|
1995-05-01 |
2000-09-26 |
Massachusetts Institute Of Technology |
Tissue engineered tendons and ligaments
|
|
US6095148A
(en)
|
1995-11-03 |
2000-08-01 |
Children's Medical Center Corporation |
Neuronal stimulation using electrically conducting polymers
|
|
US5902599A
(en)
|
1996-02-20 |
1999-05-11 |
Massachusetts Institute Of Technology |
Biodegradable polymer networks for use in orthopedic and dental applications
|
|
EP0910409A4
(en)
|
1996-03-05 |
2003-03-19 |
Scripps Research Inst |
RECOMBINANT GENE CONSTRUCTS ENCODING T-CELL RECEPTORS SPECIFIC TO HUMAN-RESTRICTED TUMORANTANTIGENS
|
|
US5969102A
(en)
|
1997-03-03 |
1999-10-19 |
St. Jude Children's Research Hospital |
Lymphocyte surface receptor that binds CAML, nucleic acids encoding the same and methods of use thereof
|
|
AU6685698A
(en)
|
1997-03-07 |
1998-09-22 |
Sunol Molecular Corporation |
Fusion proteins comprising bacteriophage coat protein and a single-chain t cell receptor
|
|
US5837752A
(en)
|
1997-07-17 |
1998-11-17 |
Massachusetts Institute Of Technology |
Semi-interpenetrating polymer networks
|
|
WO1999018129A1
(en)
|
1997-10-02 |
1999-04-15 |
Sunol Molecular Corporation |
Soluble single-chain t-cell receptor proteins
|
|
EP1064022A4
(en)
*
|
1998-03-13 |
2004-09-29 |
Epimmune Inc |
HLA BINDING PROTEINS AND THEIR USE
|
|
US6632922B1
(en)
|
1998-03-19 |
2003-10-14 |
The Regents Of The University Of California |
Methods and compositions for controlled polypeptide synthesis
|
|
US6506577B1
(en)
|
1998-03-19 |
2003-01-14 |
The Regents Of The University Of California |
Synthesis and crosslinking of catechol containing copolypeptides
|
|
US6686446B2
(en)
|
1998-03-19 |
2004-02-03 |
The Regents Of The University Of California |
Methods and compositions for controlled polypeptide synthesis
|
|
ES2293748T3
(es)
|
1998-10-21 |
2008-03-16 |
Altor Bioscience Corporation |
Moleculas de fijacion poliespecificas y usos de las mismas.
|
|
US20060067933A1
(en)
|
1999-01-07 |
2006-03-30 |
Gross Jane A |
Soluble receptor BR43x2 and methods of using
|
|
EP1092439A1
(en)
|
1999-10-13 |
2001-04-18 |
Thorsten Dr. Ahlert |
Activation of antigen-specific T cells by virus/antigen-treated dendritic cells
|
|
US7026443B1
(en)
|
1999-12-10 |
2006-04-11 |
Epimmune Inc. |
Inducing cellular immune responses to human Papillomavirus using peptide and nucleic acid compositions
|
|
GB9930359D0
(en)
|
1999-12-22 |
2000-02-09 |
Glaxo Group Ltd |
Novel polypeptides
|
|
CA2396793A1
(en)
|
2000-02-16 |
2001-08-23 |
Genentech, Inc. |
Uses of agonists and antagonists to modulate activity of tnf-related molecules
|
|
CN1312289A
(zh)
*
|
2000-03-07 |
2001-09-12 |
上海博德基因开发有限公司 |
一种新的多肽——人促性腺释放激素23和编码这种多肽的多核苷酸
|
|
JP2004513876A
(ja)
|
2000-04-27 |
2004-05-13 |
バイオジェン インコーポレーテッド |
抗−腫瘍剤としてのｔａｃｉ
|
|
US20020086018A1
(en)
*
|
2000-05-12 |
2002-07-04 |
Theill Lars Eyde |
Methods and compositions of matter concerning APRIL/G70, BCMA, BLYS/AGP-3, and TACI
|
|
JP2005503118A
(ja)
|
2001-02-14 |
2005-02-03 |
ジェンザイム・コーポレーション |
改変ペプチドリガンド
|
|
US20030012783A1
(en)
|
2001-02-20 |
2003-01-16 |
Wayne Kindsvogel |
Antibodies that bind both BCMA and TACI
|
|
BRPI0209933B8
(pt)
|
2001-05-24 |
2021-05-25 |
Zymogenetics Inc |
proteína de fusão, e, molécula de ácido nucleico
|
|
BR0211614A
(pt)
|
2001-08-03 |
2006-10-31 |
Genentech Inc |
polipeptìdeo tacis e br3 e empregos dos mesmos
|
|
US6818732B2
(en)
|
2001-08-30 |
2004-11-16 |
The Regents Of The University Of California |
Transition metal initiators for controlled poly (beta-peptide) synthesis from beta-lactam monomers
|
|
US20040072246A1
(en)
|
2001-09-11 |
2004-04-15 |
Roland Martin |
System and method for identifying t cell and other epitopes and the like
|
|
WO2005037995A2
(en)
|
2003-10-06 |
2005-04-28 |
Cedars-Sinai Medical Center |
Use of cox-2 inhibitor to prevent t-cell anergy induced by dendritic cell therapy
|
|
WO2005043155A1
(en)
|
2003-10-21 |
2005-05-12 |
Cedars-Sinai Medical Center |
System and method for the treatment of cancer, including cancers of the central nervous system
|
|
WO2008143679A2
(en)
*
|
2006-06-01 |
2008-11-27 |
Verenium Corporation |
Nucleic acids and proteins and methods for making and using them
|
|
EP2630966B1
(en)
|
2007-10-12 |
2017-04-19 |
Massachusetts Institute of Technology |
Vaccine nanotechnology
|
|
WO2010037395A2
(en)
*
|
2008-10-01 |
2010-04-08 |
Dako Denmark A/S |
Mhc multimers in cancer vaccines and immune monitoring
|
|
US8343498B2
(en)
|
2008-10-12 |
2013-01-01 |
Massachusetts Institute Of Technology |
Adjuvant incorporation in immunonanotherapeutics
|
|
EP4012714A1
(en)
*
|
2010-03-23 |
2022-06-15 |
Iogenetics, LLC. |
Bioinformatic processes for determination of peptide binding
|
|
JP6378172B2
(ja)
|
2012-05-22 |
2018-08-22 |
アメリカ合衆国 |
マウス抗ｎｙ−ｅｓｏ−１ｔ細胞受容体
|
|
CA2888803A1
(en)
*
|
2012-11-05 |
2014-05-08 |
Jooeun Bae |
Xbp1, cd138, and cs1 peptides, pharmaceutical compositions that include the peptides, and methods of using such peptides and compositions
|
|
US10377808B2
(en)
|
2013-01-29 |
2019-08-13 |
Max-Delbrück-Centrum Für Molekulare Medizin (Mdc) Berlin-Buch |
High avidity antigen recognizing constructs
|
|
BR112015021970A2
(pt)
|
2013-03-14 |
2017-07-18 |
Massachusetts Inst Technology |
composições à base de nanopartículas
|
|
CN110511960B
(zh)
|
2013-07-15 |
2023-05-23 |
美国卫生和人力服务部 |
抗人乳头瘤病毒16 e6 t细胞受体
|
|
US20150038682A1
(en)
|
2013-08-02 |
2015-02-05 |
Jn Biosciences Llc |
Antibodies or fusion proteins multimerized via homomultimerizing peptide
|
|
EP3060656A1
(en)
|
2013-10-24 |
2016-08-31 |
Yeda Research and Development Co., Ltd. |
Polynucleotides encoding brex system polypeptides and methods of using same
|
|
WO2015158671A1
(en)
*
|
2014-04-14 |
2015-10-22 |
Cellectis |
Bcma (cd269) specific chimeric antigen receptors for cancer immunotherapy
|
|
SG10201912038TA
(en)
|
2014-04-23 |
2020-02-27 |
Modernatx Inc |
Nucleic acid vaccines
|
|
CA2967778C
(en)
|
2014-11-14 |
2024-04-16 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Anti-thyroglobulin t cell receptors
|
|
SG11201705264WA
(en)
|
2014-12-31 |
2017-07-28 |
The Usa As Represented By The Secretary Detp Of Health And Human Services |
Novel multivalent nanoparticle-based vaccines
|
|
HK1253694A1
(zh)
|
2015-06-01 |
2019-06-28 |
Medigene Immunotherapies Gmbh |
T细胞受体文库
|
|
US10228101B2
(en)
|
2015-07-01 |
2019-03-12 |
Mind Head Llc |
LED light fixtures and LED lamps that are used to replace Par 36 halogen lamps and incandescent well lights
|
|
US10072088B2
(en)
*
|
2015-08-17 |
2018-09-11 |
Janssen Pharmaceutica, Nv |
Anti-BCMA antibodies and uses thereof
|
|
CN109414455B
(zh)
|
2016-04-01 |
2023-01-20 |
凯德药业股份有限公司 |
Bcma结合分子及其使用方法
|
|
EP4282877A3
(en)
*
|
2016-08-10 |
2024-02-21 |
Legend Biotech Ireland Limited |
Chimeric antigen receptors targeting bcma and methods of use thereof
|
|
DE102016115246C5
(de)
|
2016-08-17 |
2018-12-20 |
Immatics Biotechnologies Gmbh |
Neue t-zellrezeptoren und deren verwendung in immuntherapie
|
|
CN110352068A
(zh)
|
2016-12-02 |
2019-10-18 |
南加利福尼亚大学 |
合成的免疫受体及其使用方法
|
|
IL268349B2
(en)
|
2017-02-17 |
2024-08-01 |
Hutchinson Fred Cancer Res |
Combination therapies for treatment of bcma-related cancers and autoimmune disorders
|
|
US12448429B2
(en)
|
2019-03-06 |
2025-10-21 |
Dana-Farber Cancer Institute, Inc. |
T cell receptors specific to b-cell maturation antigen for treatment of cancer
|